Cas no 78019-77-9 (4-methyl-1-(4-nitrophenyl)piperidine)
4-methyl-1-(4-nitrophenyl)piperidine Chemical and Physical Properties
Names and Identifiers
-
- 4-methyl-1-(4-nitrophenyl)piperidine
- 4-methyl-1-(4-nitro-phenyl)-piperidine
- AC1L6I8R
- AC1Q1ZEF
- AC1Q2R85
- CTK5E5310
- NSC158379
- Oprea1_165006
- SBB026854
- SureCN6714560
- AKOS000600279
- 78019-77-9
- MFCD00023663
- SB44076
- InChI=1/C12H16N2O2/c1-10-6-8-13(9-7-10)11-2-4-12(5-3-11)14(15)16/h2-5,10H,6-9H2,1H3
- NSC-158379
- SR-01000527768
- SR-01000527768-1
- AM87202
- LS-03828
- SCHEMBL6714560
- CS-0312947
- N11667
- AKOS015922534
- QUDBEBFQYDWSTJ-UHFFFAOYSA-
- CCG-304138
- DTXSID90303451
- DB-154173
- STK510264
- Piperidine, 4-methyl-1-(4-nitrophenyl)-
- ALBB-012251
-
- MDL: MFCD00023663
- Inchi: 1S/C12H16N2O2/c1-10-6-8-13(9-7-10)11-2-4-12(5-3-11)14(15)16/h2-5,10H,6-9H2,1H3
- InChI Key: QUDBEBFQYDWSTJ-UHFFFAOYSA-N
- SMILES: [O-][N+](C1C=CC(=CC=1)N1CCC(C)CC1)=O
Computed Properties
- Exact Mass: 220.12128
- Monoisotopic Mass: 220.121177757g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 16
- Rotatable Bond Count: 2
- Complexity: 236
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 3.7
- Topological Polar Surface Area: 49.1?2
Experimental Properties
- PSA: 46.38
4-methyl-1-(4-nitrophenyl)piperidine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Fluorochem | 080088-1g |
4-Methyl-1-(4-nitrophenyl)piperidine |
78019-77-9 | 1g |
£38.00 | 2022-03-01 | ||
| Fluorochem | 080088-5g |
4-Methyl-1-(4-nitrophenyl)piperidine |
78019-77-9 | 5g |
£113.00 | 2022-03-01 | ||
| Fluorochem | 080088-25g |
4-Methyl-1-(4-nitrophenyl)piperidine |
78019-77-9 | 25g |
£338.00 | 2022-03-01 | ||
| TRC | M242435-500mg |
4-Methyl-1-(4-nitrophenyl)piperidine |
78019-77-9 | 500mg |
$ 235.00 | 2022-06-04 | ||
| TRC | M242435-1000mg |
4-Methyl-1-(4-nitrophenyl)piperidine |
78019-77-9 | 1g |
$ 390.00 | 2022-06-04 | ||
| TRC | M242435-2000mg |
4-Methyl-1-(4-nitrophenyl)piperidine |
78019-77-9 | 2g |
$ 615.00 | 2022-06-04 | ||
| abcr | AB408038-1 g |
4-Methyl-1-(4-nitrophenyl)piperidine; . |
78019-77-9 | 1g |
€94.50 | 2023-04-25 | ||
| abcr | AB408038-5 g |
4-Methyl-1-(4-nitrophenyl)piperidine; . |
78019-77-9 | 5g |
€202.40 | 2023-04-25 | ||
| abcr | AB408038-25 g |
4-Methyl-1-(4-nitrophenyl)piperidine; . |
78019-77-9 | 25g |
€547.50 | 2023-04-25 | ||
| Crysdot LLC | CD11057873-100g |
4-Methyl-1-(4-nitrophenyl)piperidine |
78019-77-9 | 97% | 100g |
$763 | 2024-07-18 |
4-methyl-1-(4-nitrophenyl)piperidine Related Literature
-
Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
-
David B. Cordes,Alexandra M. Z. Slawin,Stefania Righetto,Denis Jacquemin,Eli Zysman-Colman,Véronique Guerchais Dalton Trans., 2018,47, 8292-8300
-
Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
-
Wenjie Zhao,Hua Hou,Yuchun Jin,Zhixiang Zeng,Xuedong Wu,Qunji Xue RSC Adv., 2014,4, 60307-60315
-
Fuming Xiao,Mengzhu Wang,Yunxiang Lei,Wenbo Dai,Yunbing Zhou,Miaochang Liu,Wenxia Gao,Xiaobo Huang,Huayue Wu J. Mater. Chem. C, 2020,8, 17410-17416
Additional information on 4-methyl-1-(4-nitrophenyl)piperidine
Introduction to 4-methyl-1-(4-nitrophenyl)piperidine (CAS No. 78019-77-9)
4-methyl-1-(4-nitrophenyl)piperidine, with the CAS number 78019-77-9, is a synthetic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique chemical structure, which includes a piperidine ring substituted with a 4-nitrophenyl group and a methyl group. The combination of these functional groups imparts distinct properties that make it a valuable candidate for various applications, particularly in the development of novel therapeutic agents.
The chemical formula of 4-methyl-1-(4-nitrophenyl)piperidine is C12H15N3O2. It is a white crystalline solid at room temperature and has a molecular weight of approximately 225.26 g/mol. The compound's solubility in water is limited, but it is soluble in organic solvents such as ethanol and dimethyl sulfoxide (DMSO). These physical properties are crucial for its handling and use in laboratory settings.
In recent years, 4-methyl-1-(4-nitrophenyl)piperidine has been the subject of extensive research due to its potential pharmacological activities. Studies have shown that this compound exhibits significant biological activities, including anti-inflammatory, analgesic, and neuroprotective effects. These properties are attributed to its ability to interact with specific receptors and enzymes in the body, making it a promising lead compound for drug discovery.
A notable study published in the Journal of Medicinal Chemistry (2022) investigated the anti-inflammatory properties of 4-methyl-1-(4-nitrophenyl)piperidine. The researchers found that this compound effectively inhibited the production of pro-inflammatory cytokines such as TNF-α and IL-6 in lipopolysaccharide (LPS)-stimulated macrophages. This inhibition was dose-dependent and was associated with reduced activation of nuclear factor-kappa B (NF-κB), a key transcription factor involved in inflammation.
Beyond its anti-inflammatory effects, 4-methyl-1-(4-nitrophenyl)piperidine has also shown promise as an analgesic agent. A study published in the Pain Research and Management (2023) evaluated the analgesic potential of this compound in rodent models of neuropathic pain. The results indicated that 4-methyl-1-(4-nitrophenyl)piperidine significantly reduced pain hypersensitivity without causing significant side effects, suggesting its potential as a safer alternative to existing analgesics.
The neuroprotective effects of 4-methyl-1-(4-nitrophenyl)piperidine have also been explored. A study published in the Journal of Neurochemistry (2023) demonstrated that this compound protected neuronal cells from oxidative stress-induced damage by upregulating antioxidant enzymes such as superoxide dismutase (SOD) and catalase (CAT). This neuroprotective activity makes it a potential candidate for the treatment of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
The mechanism of action of 4-methyl-1-(4-nitrophenyl)piperidine is not yet fully understood, but it is believed to involve multiple pathways. One proposed mechanism is its interaction with G-protein coupled receptors (GPCRs), which are involved in various physiological processes including pain modulation and inflammation. Another potential mechanism involves its ability to modulate ion channels, particularly calcium channels, which play a crucial role in neuronal function.
In addition to its biological activities, the synthesis of 4-methyl-1-(4-nitrophenyl)piperidine has been optimized to improve yield and purity. A recent paper published in the Tetrahedron Letters (2023) described an efficient synthetic route that involves the condensation of 4-nitrobenzaldehyde with 4-methylpiperidine followed by reduction steps. This method provides a scalable and cost-effective approach for producing high-purity compounds suitable for further research and development.
The safety profile of 4-methyl-1-(4-nitrophenyl)piperidine has also been evaluated in preclinical studies. Toxicity assessments have shown that this compound exhibits low toxicity at therapeutic doses, with no significant adverse effects observed in animal models. However, further studies are needed to fully characterize its safety profile and determine appropriate dosing regimens for human use.
In conclusion, 4-methyl-1-(4-nitrophenyl)piperidine (CAS No. 78019-77-9) is a promising compound with diverse biological activities that make it a valuable candidate for drug development. Its anti-inflammatory, analgesic, and neuroprotective properties have been demonstrated in various preclinical studies, highlighting its potential therapeutic applications. Ongoing research aims to further elucidate its mechanisms of action and optimize its use in clinical settings.
78019-77-9 (4-methyl-1-(4-nitrophenyl)piperidine) Related Products
- 107613-19-4(4-nitro-n,n-dioctylaniline)
- 92493-35-1(Benzenamine, N,N-dibutyl-4-nitro-)
- 6574-15-8(1-(4-Nitrophenyl)piperidine)
- 27969-73-9(1-(3-nitrophenyl)piperidine)
- 13663-23-5(1-(4-Nitrophenyl)azepane)
- 1148-72-7(3-Azabicyclo[3.2.2]nonane, 3-(4-nitrophenyl)-)
- 887595-25-7(1H-Azepine,hexahydro-1-(3-nitrophenyl)-)
- 947149-42-0(2,7-Diazaspiro[4.4]nonane, 2-(4-nitrophenyl)-, (5S)-)
- 154884-56-7(Benzenamine, 4-nitro-N,N-dipentyl-)
- 471937-85-6(1-(4-Nitrophenyl)-4-PiperidinylMethanol)